2019
DOI: 10.1016/j.ccell.2019.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
24
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(28 citation statements)
references
References 0 publications
4
24
0
Order By: Relevance
“…While activated Wnt/β-catenin signaling alone cannot drive tumorigenesis of the bronchiolar epithelium, its activation in the setting of KrasG12D mutations accelerates disease progression 121 . Further, KrasG12D ; p53 fl/fl ; Prkci (KPI) lung adenocarcinoma (LADC) mouse model tumors arise from Tm4sf1 + Axin2+ ATII cells whereas KrasG12D ; p53 fl/fl (KP) tumors arise from BASCs 122 . In addition, KPI tumors are reliant on higher levels of Wnt/β-catenin signaling for their expansion, a signature that is also reflected in human patient tumors 122 .…”
Section: Disease Pathogenesismentioning
confidence: 99%
See 1 more Smart Citation
“…While activated Wnt/β-catenin signaling alone cannot drive tumorigenesis of the bronchiolar epithelium, its activation in the setting of KrasG12D mutations accelerates disease progression 121 . Further, KrasG12D ; p53 fl/fl ; Prkci (KPI) lung adenocarcinoma (LADC) mouse model tumors arise from Tm4sf1 + Axin2+ ATII cells whereas KrasG12D ; p53 fl/fl (KP) tumors arise from BASCs 122 . In addition, KPI tumors are reliant on higher levels of Wnt/β-catenin signaling for their expansion, a signature that is also reflected in human patient tumors 122 .…”
Section: Disease Pathogenesismentioning
confidence: 99%
“…Further, KrasG12D ; p53 fl/fl ; Prkci (KPI) lung adenocarcinoma (LADC) mouse model tumors arise from Tm4sf1 + Axin2+ ATII cells whereas KrasG12D ; p53 fl/fl (KP) tumors arise from BASCs 122 . In addition, KPI tumors are reliant on higher levels of Wnt/β-catenin signaling for their expansion, a signature that is also reflected in human patient tumors 122 .…”
Section: Disease Pathogenesismentioning
confidence: 99%
“…Notwithstanding work in these ex vivo models, a lack of an absolute requirement for PKC family genes for cell division in vivo in the mouse (all knockouts are viable excepting PKCι and PKN2), suggests that for the controls operating to progress a ‘normal’ cell cycle, these proteins are not required. Furthermore, in the case of PKCι, conditional knockout in the adult does not prevent the transformation of AT2 cells in the lung by mutant Ras ( Yin et al, 2019 ), consistent with the lack of any fundamental requirement in the cell cycle. A similar argument can be made for PKN2 where the knockout appears to display selective defects in mesenchymal tissue ( Quetier et al, 2016 ).…”
Section: Introductionmentioning
confidence: 75%
“…Also, some studies have shown that changes in the cell cycle [29]- [31], like the abnormal expression of cell cyclerelated molecules of topoisomerase (DNA) II alpha (TOP2A), cyclin-dependent kinase 1 (CDK1) may affect the occurrence and development of LUAD [32], [33]. Meanwhile, LUAD has been reported to be associated with abnormal signal pathways [34], [35], such as the Ras / Raf / MEK / ERK classic tumor signaling pathway [36], [37]. Surgery and postoperative chemotherapy are the gold standards for the treatment of advanced and metastatic nonsmall cell lung cancer, but as the effective rate of the current first-line treatment is no more than 20-30% [38], it is still essential to discover the molecular mechanism in the occurrence and development of LUAD.…”
Section: Related Workmentioning
confidence: 99%